| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $10.1B | $9.9B | $10.4B | $9.4B | $1.9B | $2.5B | $2.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.3B | $3.5B | $3.3B | $3.6B | $3.3B | $3.0B | $3.2B | $3.0B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.3B | $0.1B | $0.6B | $0.3B | $-0.4B | $-0.1B | $-0.4B |
| EPS (Basic) | $1.31 | $0.47 | $0.26 | $1.06 | $0.56 | $-0.67 | $0.27 | — |
| EPS (Diluted) | $1.31 | $0.46 | $0.26 | $1.05 | $0.56 | $-0.67 | $0.26 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.5B | $16.7B | $16.9B | $17.2B | $16.8B | $14.3B | $15.7B | $16.3B |
| Current Assets | $4.8B | $4.4B | $4.1B | $4.1B | $4.5B | $3.5B | $4.0B | $4.4B |
| Cash & Equivalents | $2.4B | $2.0B | $1.8B | $1.8B | $2.2B | $1.5B | $1.6B | $2.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.6B | $3.1B | $3.2B | $3.5B | $3.2B | $2.7B | $3.3B | $3.3B |
| Stockholders' Equity | $8.8B | $8.1B | $8.1B | $8.2B | $8.2B | $7.6B | $9.1B | $9.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $1.1B | $1.1B | $1.4B | $1.2B | $0.8B | $0.9B | $0.8B |
| Investing Cash Flow | — | $-0.5B | $-0.6B | $-2.1B | $-1.3B | $-0.4B | $-0.7B | $-0.3B |
| Capital Expenditures | $0.4B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.6B | $0.4B |
| Financing Cash Flow | — | $-0.4B | $-0.5B | $0.4B | $0.7B | $-0.5B | $-0.6B | $-0.4B |